Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged. Beyond helping people shed pounds, they also lower the risk of heart disease and sleep apnea—and the U.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Clinical trials have found that people who are on the prescription for a year can lose more than 10% of their body weight.

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake.

S emaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and consumption in a small trial involving peop

The new findings add to growing evidence that the medicines could help people with alcohol addiction. View on euronews

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.